Ravi K Amaravadi

12PUBLICATIONS
99CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Food properties (incl. characteristics and health benefits)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.

|Sep 12, 2024
Divergent effects of acute and chronic PPT1 inhibition in melanoma.

Mary Ann S Crissey, Amanda Versace, Monika Bhardwaj

|Sep 09, 2024
Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti-PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival.

Kevin L Ma, Tara C Mitchell, Meaghan Dougher

|Jun 17, 2024
A Multimodal Drug-Diet-Immunotherapy Combination Restrains Melanoma Progression and Metastasis.

Nicole Oatman, Mruniya V Gawali, Sunny Congrove

|Jan 24, 2024
FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma.

Thomas M Anderson, Bryan H Chang, Alexander C Huang

|Jun 28, 2023
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma.

Payal D Shah, Alexander C Huang, Xiaowei Xu

Pageof 2

Frequent Collaborators

4 joint publications

Alexander C Huang

4 joint publications

Xiaowei Xu

4 joint publications

Tara C Mitchell

4 joint publications

Lynn M Schuchter